Cargando…
Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions
The sale of unproven stem cell interventions (SCIs) by commercial entities has proliferated in highly developed countries, most notably in the USA. Yet, there have been few criminal prosecutions and regulatory enforcement actions against providers who have violated laws and best practice standards d...
Autores principales: | Horner, Claire, Tenenbaum, Evelyn, Sipp, Douglas, Master, Zubin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818472/ https://www.ncbi.nlm.nih.gov/pubmed/29479481 http://dx.doi.org/10.1038/s41536-018-0043-6 |
Ejemplares similares
-
Unproven stem cell interventions: A global public health problem requiring global deliberation
por: Master, Zubin, et al.
Publicado: (2021) -
The malignant niche: safe spaces for toxic stem cell marketing
por: Sipp, Douglas
Publicado: (2017) -
Designing persuasive health education for patients seeking unproven stem cell interventions
por: Kawam, Omar, et al.
Publicado: (2023) -
How to Peddle Hope: An Analysis of YouTube Patient Testimonials of Unproven Stem Cell Treatments
por: Hawke, Bethany, et al.
Publicado: (2019) -
Civil Lawsuits as an Indicator of Adverse Outcomes in Healthcare
por: Mikos, Marcin, et al.
Publicado: (2022)